Advertisement

 

 

Dolutegravir and neuropsychiatric adverse events: a continuing debate.

Dolutegravir and neuropsychiatric adverse events: a continuing debate.
Author Information (click to view)

Cailhol J, Rouyer C, Alloui C, Jeantils V,


Cailhol J, Rouyer C, Alloui C, Jeantils V, (click to view)

Cailhol J, Rouyer C, Alloui C, Jeantils V,

Advertisement

AIDS (London, England) 31(14) 2023-2024 doi 10.1097/QAD.0000000000001596

Abstract

Submit a Comment

Your email address will not be published. Required fields are marked *

nineteen − 5 =

[ HIDE/SHOW ]